Compare CCBG & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCBG | QDEL |
|---|---|---|
| Founded | 1895 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 874.1M | 989.5M |
| IPO Year | 1994 | 2022 |
| Metric | CCBG | QDEL |
|---|---|---|
| Price | $51.12 | $13.86 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $50.00 | $28.25 |
| AVG Volume (30 Days) | 50.3K | ★ 1.6M |
| Earning Date | 04-20-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.34% | N/A |
| EPS Growth | 15.38 | ★ 45.35 |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $6.25 | $3.51 |
| Revenue Next Year | $3.17 | $3.86 |
| P/E Ratio | $55.41 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $38.27 | $9.92 |
| 52 Week High | $53.60 | $35.58 |
| Indicator | CCBG | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 48.48 | 42.37 |
| Support Level | $50.98 | $13.04 |
| Resistance Level | $51.04 | $17.86 |
| Average True Range (ATR) | 0.93 | 0.87 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 37.57 | 28.10 |
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.